Month: February 2013 (page 8 of 13)

thinking is harder in the heat

SciAm profiles a series of studies on temperature and cognition. Researchers at the University of Virginia and the University of Houston tested and compared decision making skills at warm and cooler temperatures. They found significant performance drop-offs when participants were kept at warmer temperatures. Excerpt:

The researchers decided to test this apparent link between weather and complex decision-making in the lab by performing a series of experiments comparing participants’ cognitive performance at two seemingly unremarkable temperatures: 67° and 77° Fahrenheit. People tend to be most comfortable at around 72° Fahrenheit, so each temperature represented just a 5° deviation from maximum comfort.

Despite this minimal deviation in temperature, the researchers found remarkable differences in cognitive functioning. In one lab study, participants were asked to proofread an article while they were in either a warm (77°) or a cool (67°) room. Participants in warm rooms performed significantly worse than those in cool rooms, failing to identify almost half of the spelling and grammatical errors (those in cool rooms, on the hand, only missed a quarter of the mistakes). These results suggest that even simple cognitive tasks can be adversely affected by excessive ambient warmth.

In a second study, the researchers showed similar effects for more complex cognitive calculations. In this study, another group of participants were asked to choose between two cell phone plans, again in either a warm or a cool room. One plan looked more attractive on the surface, but was actually more expensive; simple patterns of decision-making would therefore lead participants to choose the more expensive plan, whereas more complex analyses would lead participants to correctly choose the more cost-effective plan. Participants in the cool room made the correct choice over half the time; those in the warm room, on the other hand, made the correct choice only a quarter of the time. Warmer temperatures seemed to make participants more likely to rely on simplistic patterns of decision-making, which in turn led to inferior choices. These results suggest that complex decision-making, like simple cognitive tasks, is adversely affected by warm temperatures.

More at the link, including summary of a third study.

curosity meets rock

Curiosity rover rock

Mars curiosity drilled this hole in this rock.

The Mars rover Curiosity has drilled the first ever hole into Martian rocks. From Alicia Chang:

Using the drill at the end of its 7-foot-long robotic arm, Curiosity on Friday chipped away at a flat, veined rock bearing numerous signs of past water flow. After nearly seven minutes of pounding, the result was a drill hole 2 1/2 -inches deep.

The exercise was so complex that engineers spent several days commanding Curiosity to tap the rock outcrop, drill test holes and perform a ‘‘mini-drill’’ in anticipation of the real show. Images beamed back to Earth overnight showed a fresh borehole next to a shallower test hole Curiosity had made earlier.

‘‘It was a perfect execution,’’ drill engineer Avi Okon at the NASA Jet Propulsion Laboratory said Saturday.

Previous Mars landings carried tools that scraped away the exterior layers of rocks and dirt. Opportunity and Spirit — before it died — toted around a rock grinder. Phoenix, which touched down near the Martian north pole in 2008, was equipped with an ice rasp to chisel frozen soil.

Now onto analyzing the rock’s chemical make up.

a new tuberculosis vaccine falls short

tuberculosis

Tuberculosis bacteria

A new study of the potential tuberculosis vaccine, modified Vaccinia Ankara virus expressing antigen 85A (MVA85A), has failed in a study of 3000 infants in South Africa. Scientists had hoped it would help improve protection against the infection when used with the current vaccination (BCG). The study was a double-blind, randomised, placebo-controlled trial of healthy infants (aged 4—6 months). The infants were randomly administered BCG with either MVA85A or a placebo of Candida skin test antigen then examined every 3 months for up to 3 years. During the course of the trial, the rates of serious or systemic infection from tuberculosis were similar for the group that received the new vaccine enhancer compared to those given the placebo. The researchers did note that the MVA85A does appear to be safe and that no adverse effects were cause by the antigen itself. This was the first efficacy trial of a tuberculosis vaccine in infants in more than 45 years. More details here at The Lancet [subscription required].

//glakraptaidsupi.net/4/4535925